Prometheus Laboratories Inc. recalls Mercaptopurine Tablets, USP 50mg, a) 60-count bottle (NDC 49884-922-02), b) 250-count bottle (NDC 49884-922-04), RX onl
Recalled November 26, 2014 · FDA recall D-0249-2015 · Prometheus Laboratories
Hazard
Failed Dissolution Specifications: Product found to be out of specification (OOS) during stability testing. · FDA Class II
Units
16,296 bottles (60-count), 5,166 bottles (250-count)
Sold at
Nationwide
Description
Failed Dissolution Specifications: Product found to be out of specification (OOS) during stability testing.
Product
Mercaptopurine Tablets, USP 50mg, a) 60-count bottle (NDC 49884-922-02), b) 250-count bottle (NDC 49884-922-04), RX only, Manufactured by Stason Pharmaceuticals, Inc., 11 Morgan, Irvine, CA 92618 for Prometheus Laboratories, Inc., 9410 Carroll Park Drive, San Diego, CA 92121
Manufacturer(s)
Prometheus Laboratories Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →